Sino Biopharmaceutical Limited (02509.HK) spent approximately 99.88 million Hong Kong dollars to repurchase 52,000 shares on November 11th.

The Economic Information APP of Wisdom Finance reports that Quanxin Biotechnology-B (02509.HK) announced that on November 11, 2025, it spent approximately HK$998,800 to repurchase 52,000 shares.